Video Experimental Relacionado
Updated: Jun 22, 2026
05:28
A Semi-Quantitative Drug Affinity Responsive Target Stability (DARTS) assay for studying Rapamycin/mTOR interaction
Published on: August 27, 2019
GOLPH3 modula la señalización mTOR y la sensibilidad a la rapamicina en el cáncer
Kenneth L Scott1, Omar Kabbarah, Mei-Chih Liang
1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Nature
|June 26, 2009
Resumen
Una amplificación frecuente de 5p13 se dirige a la proteína de Golgi GOLPH3, identificada como un potente oncogén. GOLPH3 regula el tamaño celular y la señalización mTOR, influyendo en el crecimiento del cáncer y la respuesta al tratamiento con rapamicina.
Área de la Ciencia:
- Oncología Oncología.
- Biología Molecular Biología Molecular
- Genética La genética.
Sus antecedentes:
- Amplificación frecuente de 5p13 observada en diversos tumores sólidos como el pulmón, el ovario, el seno, la próstata y el melanoma.
- GOLPH3 (Golgi phosphoprotein 3) emerge como un gen candidato dentro de la región amplificada 5p13.
Objetivo del estudio:
- Para identificar el gen específico al que apunta la amplificación 5p13.
- Para caracterizar funcionalmente GOLPH3 como un oncogén potencial.
- Para aclarar el mecanismo por el cual GOLPH3 contribuye al desarrollo del cáncer y la respuesta a los medicamentos.
Principales métodos:
- Perfiles genómicos integrales de la región 5p13.
- Estudios in vitro e in vivo de ganancia y pérdida de función.
- Análisis bioquímicos para determinar la localización e interacciones de GOLPH3.
- Análisis de la vía de señalización de mTOR y respuesta a los inhibidores de mTOR.
Principales resultados:
- GOLPH3 fue identificado como el gen objetivo de la amplificación 5p13.
- GOLPH3 funciona como un potente oncogén, regulando el tamaño celular y mejorando la señalización mTOR inducida por el factor de crecimiento.
- GOLPH3 interactúa con el complejo de retrómero e influye en la respuesta a los inhibidores de mTOR como la rapamicina.
Conclusiones:
- GOLPH3 es un oncogén recientemente identificado amplificado con frecuencia en cánceres humanos.
- GOLPH3 juega un papel crítico en la proliferación y supervivencia de las células cancerosas a través de la modulación de la vía mTOR.
- La amplificación de GOLPH3 y su papel en la señalización mTOR sugieren posibles estrategias terapéuticas dirigidas a la respuesta de la rapamicina.
Videos de Conceptos Relacionados
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
01:19Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
01:24Small GTPases - Ras and Rho
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
02:38The Ras Gene
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Ras is a superfamily...